Neurostimulation Applied to Fibromyalgia

Neurostimulation Applied to Fibromyalgia

NeuroFibro is a double-blind, randomized, placebo-controlled clinical trial, using neurostimulation in women with fibromyalgia.

Inclusion Criteria:

• (1) diagnosis of fibromyalgia, according to the American College of Rheumatology criteria;
• (2) been diagnosed for at least three months;
• (3) be female;
• (4) be in the age group between 25 and 60 years of age; and
• (5) sign the consent form.

Exclusion Criteria:

• (1) cognitive deficit, evaluated through the Mini Mental State Examination (MMSE);
• (2) illiterate;
• (3) people with metallic implants located on the head, cochlear implants and cardiac pacemaker;
• (4) history of convulsion;
• (5) severe depression, measured by score greater than 36 on Beck Depression Inventory; and
• (6) be pregnant.